31 presentations were found matching your search word(s) with International Session(Workshop)

International Session (Workshop)1 (JSGE, JSH)

November 4, 15:00–17:00, Room 11 (Portopia Hotel South Wing Topaz)

New developments in drug discovery research and treatment for hepatitis B

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  IS-W1-1_H，IS-W1-5_G，IS-W1-8_G : 10 min. for oral presentation, 2 min. for Q&A
  Other Presentations: 8 min. for oral presentation, 2 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
  • Chairperson:
    Tatsuya KantoThe Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine
  • Chairperson:
    Yasuhito TanakaDepartment of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University
  • Discussant:
    Kenichi MorikawaDepartment of Gastroenterology and Hepatology, Hokkaido University
  • Discussant:
    Sachiyo YoshioDepartment of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine

IS-W1-1_H
Enhancing functional cure in patients with chronic hepatitis B infection

Lung-Yi Mak The University of Hong Kong

IS-W1-2_H
DOCK11 might be a candidate druggable target for HBV cure

Ying-Yi Li Department of Gastroenterology, Kanazawa University Graduate School of Medicine

IS-W1-3_G
Identification of an Interferon-Inducible Regulatory Molecule, IFI44L, for Hepatitis B Virus cccDNA in Primary Human Hepatocytes

Takuto Nosaka Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui

IS-W1-4_H
Novel anti-HBV combination treatment of CRISPR/Cas9 and suppression of NHEJ-mediated DNA repair Young Award

Kazuhiro Murai Department of Gastroenterology and Hepatology, Osaka University, Graduate School of Medicine

IS-W1-5_G
CRISPR-mediated genome editing for HBV Cure: the promise and challenge

Hung-Chih Yang National Taiwan University College of Medicine

IS-W1-6_H
Exosome-associated tetraspanin CD63 is a potential target for the inhibition of infectious envelope formation of hepatitis B virus

Jun Inoue Department of Gastroenterology, Tohoku University Hospital

IS-W1-7_G
SA-5, A novel oral agonist of Toll-like Receptor (TLR) 7, induces HBs antigen specific immune reaction in chronic HBV infection model mice

Takayasu Ideta Department of Laboratory Medicine, Gifu University Graduate School of Medicine

IS-W1-8_G
Impact of HBsAg on virus-specific T cells in chronic HBV infection

Nina Le Bert Duke-NUS Medical School

IS-W1-9_H
OX40 stimulation of HBV-specific CD8+ T cells achieves long-term HBs suppression.

Masanori Isogawa Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases

IS-W1-10_G
HBsAg reduction was evident in 30 months follow-up after administration with therapeutic vaccine containing HBs/HBc antigen in chronic HBV carriers

Osamu Yoshida Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine

Page Top

International Session (Workshop)2 (JSGS)

November 5, 14:30–16:30, Room 5 (Portopia Hotel South Wing Ohwada A)

Robotic surgery for GI cancer in Asia

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  IS-W2-Special Remarks : 5 min. for oral presentation
  IS-W2-1_S，IS-W2-5_S : 15 min. for oral presentation, 3 min. for Q&A
  Other Presentations: 10 min. for oral presentation, 3 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
  • Chairperson:
    Soji OzawaDepartment of Surgery, Tamakyuryo Hospital
  • Chairperson:
    Yusuke KinugasaDepartment of Gastrointestinal Surgery, Tokyo Medical and Dental University
  • Discussant:
    Woo Jin HyungDepartment of Surgery, Yonsei University College of Medicine

IS-W2-1_S

Young-Woo Kim Center for Gastric Cancer, National Cancer Center

IS-W2-2_S
Current Status and Future Prospects of Robot-Assisted Gastric Cancer Surgery in Japan

Ichiro Uyama Advanced Robotic and Endoscopic Surgery, Fujita Health University

IS-W2-3_S
Comparison of robotic and laparoscopic gastrectomy for gastric cancer- Propensity score-matched analysis –

Masaaki Nishi Department of Surgery, Tokushima University

IS-W2-4_S
Robot-assisted esophagectomy may be a promising alternative to the conventional thoracoscopic approach

Shigeru Tsunoda Department of Surgery, Kyoto University

IS-W2-5_S
Robotic Surgery for GI cancer in Asia

Hye-Jin Kim Kyungpook National University

IS-W2-6_S
Clinical benefits of robotic surgery for rectal cancer

Akio Shiomi Division of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital

IS-W2-7_S
Robotic surgery for colorectal cancer in Japan

Chu Matsuda Dept. Gastroenterological Surgery, Osaka International Cancer Institute

IS-W2-8_S
Advantage of robotic surgery for rectal cancer

Soichiro Ishihara The Department of Surgical Oncology, The University of Tokyo

IS-W2-Special Remarks

Yasuyuki Seto Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo

Page Top

International Session (Workshop)3 (JSH, JSGE, JSGCS)

November 5, 14:30–17:00, Room 8 (Portopia Hotel Main Building Kairaku 1+2)

Non-invasive assessment of liver fibrosis for the clinical diagnosis and treatment

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  IS-W3-Special Remarks : 8 min. for oral presentation
  IS-W3-5_H : 9 min. for oral presentation, 3 min. for Q&A
  Other Presentations: 10 min. for oral presentation, 3 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
  • Chairperson:
    Kazuhiko NakaoDepartment of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University
  • Chairperson:
    Masashi HirookaDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
  • Discussant:
    Katsutoshi SugimotoDepartment of Gastroenterology and Hepatology, Tokyo Medical University
  • Discussant:
    Osamu YoshidaDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine

IS-W3-1_H
A simple method for evaluating liver fibrosis in NAFLD using quantified hepatic venous waveform

Takuma Nakatsuka Department of Gastroenterology, The University of Tokyo

IS-W3-2_G
Usefulness of shear-wave velocity for the prediction of liver cirrhosis and esophageal varices

Shouichi Namikawa Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui

IS-W3-3_H
Examination of Shear Wave Elastography and Attenuation Imaging by Subcutaneous Thickness

Shinsuke Uchikawa Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University

IS-W3-4_H
The direct comparison for the diagnostic ability of liver fibrosis by several non-invasive methods

Takashi Nishimura Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine,Ultrasound Imaging Center, Hyogo College of Medicine

IS-W3-5_H
Usefulness of the FibroScan-AST score by vibration-controlled transient and B-mode ultrasound elastography

Yohei Koizumi Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine

IS-W3-6_H
The role of Three-Dimensional Magnetic Resonance Elastography in Nonalcoholic Steatohepatitis Young Award

Yasuyuki Komiyama Department of Gastroenterology, Faculty of Medicine, University of Yamanashi

IS-W3-7_H
Serum fragmented CK18 levels measured by highly sensitive detection system is correlated with liver fibrosis and is novel non-invasive biomarker for NASH diagnosis

Akiko Eguchi Department of Gastroenterology and Hepatology, Mie University

IS-W3-8_H
Serum exosome proteome reveals the novel fibrosis marker in chronic hepatitis C patients

Kumiko Shirai Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

IS-W3-9_H
Albumin platelet product as a novel score for liver fibrosis stage and prognosis.

Koji Fujita Departments of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University

IS-W3-10_H
Usefulness of M2BPGi and autotaxin as non-invasive biomarkers to estimate chronic liver disease status

Satoru Joshita Department of Gastroenterology, Shinshu University School of Medicine

IS-W3-11_H
Non-invasive assessments for the patients with NAFLD with obesity.

Rika Horii Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University

IS-W3-Special Remarks

Namiki Izumi Musashino Red Cross Hospital

Page Top

Page Top